SE9001985D0 - New chemical products - Google Patents

New chemical products

Info

Publication number
SE9001985D0
SE9001985D0 SE9001985A SE9001985A SE9001985D0 SE 9001985 D0 SE9001985 D0 SE 9001985D0 SE 9001985 A SE9001985 A SE 9001985A SE 9001985 A SE9001985 A SE 9001985A SE 9001985 D0 SE9001985 D0 SE 9001985D0
Authority
SE
Sweden
Prior art keywords
bssl
sequence given
vector
chemical products
new chemical
Prior art date
Application number
SE9001985A
Other languages
English (en)
Swedish (sv)
Inventor
G Bjursell
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9001985A priority Critical patent/SE9001985D0/xx
Publication of SE9001985D0 publication Critical patent/SE9001985D0/xx
Priority to ZA913778A priority patent/ZA913778B/xx
Priority to TW080103838A priority patent/TW221712B/zh
Priority to DZ910064A priority patent/DZ1503A1/fr
Priority to NZ238223A priority patent/NZ238223A/xx
Priority to MYPI91000877A priority patent/MY111245A/en
Priority to IL9827391A priority patent/IL98273A/xx
Priority to EG33391A priority patent/EG19937A/xx
Priority to MA22438A priority patent/MA22166A1/fr
Priority to YU95191A priority patent/YU49138B/sh
Priority to PCT/SE1991/000381 priority patent/WO1991018923A1/en
Priority to UA93003780A priority patent/UA39165C2/uk
Priority to AT91911030T priority patent/ATE151077T1/de
Priority to JP91510382A priority patent/JPH05507201A/ja
Priority to HU9203774A priority patent/HU215258B/hu
Priority to DK91911030.4T priority patent/DK0535048T3/da
Priority to ES91911030T priority patent/ES2099159T3/es
Priority to PL91296937A priority patent/PL166534B1/pl
Priority to SG1996006887A priority patent/SG48078A1/en
Priority to IE184491A priority patent/IE911844A1/en
Priority to AU79645/91A priority patent/AU651979B2/en
Priority to RO92-01490A priority patent/RO114793B1/ro
Priority to RU92016526/13A priority patent/RU2140983C1/ru
Priority to CA002083396A priority patent/CA2083396C/en
Priority to EP91911030A priority patent/EP0535048B1/en
Priority to DE69125489T priority patent/DE69125489T2/de
Priority to CS19911644A priority patent/CZ287470B6/cs
Priority to IS3710A priority patent/IS1751B/is
Priority to PT97836A priority patent/PT97836B/pt
Priority to SK1644-91A priority patent/SK281089B6/sk
Priority to TNTNSN91041A priority patent/TNSN91041A1/fr
Priority to JO19911694A priority patent/JO1694B1/en
Priority to CN91104368A priority patent/CN1075113C/zh
Priority to APAP/P/1991/000270A priority patent/AP207A/en
Priority to PH43285A priority patent/PH30761A/en
Priority to HRP-951/91A priority patent/HRP920771B1/xx
Priority to NO19924528A priority patent/NO322962B1/no
Priority to BG97123A priority patent/BG61165B1/bg
Priority to KR1019920703049A priority patent/KR100212411B1/ko
Priority to FI925453A priority patent/FI114639B/fi
Priority to LVP-93-1005A priority patent/LV10292B/en
Priority to LTIP1736A priority patent/LT4020B/lt
Priority to HK62497A priority patent/HK62497A/xx
Priority to GR970401262T priority patent/GR3023618T3/el
Priority to CN00130975A priority patent/CN1326782A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/596—Mixtures of surface active compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE9001985A 1990-06-01 1990-06-01 New chemical products SE9001985D0 (sv)

Priority Applications (45)

Application Number Priority Date Filing Date Title
SE9001985A SE9001985D0 (sv) 1990-06-01 1990-06-01 New chemical products
ZA913778A ZA913778B (en) 1990-06-01 1991-05-17 New chemical products
TW080103838A TW221712B (bg) 1990-06-01 1991-05-18
DZ910064A DZ1503A1 (fr) 1990-06-01 1991-05-20 Nouveaux produits chimiqués.
NZ238223A NZ238223A (en) 1990-06-01 1991-05-22 Human bile salt-stimulated lipase related proteins and their production and use
MYPI91000877A MY111245A (en) 1990-06-01 1991-05-23 New chemical products.
IL9827391A IL98273A (en) 1990-06-01 1991-05-27 Dna sequences, proteins having esterase activity coded by them and use of such proteins, pharmaceutical compositions and infant food formulations containing the proteins and processes for preparing them
EG33391A EG19937A (en) 1990-06-01 1991-05-29 A process for preparing a novel proteins are related to lipase enzyme used as food and pharmaceutical compounds
MA22438A MA22166A1 (fr) 1990-06-01 1991-05-29 Nouveaux produits chimiques
YU95191A YU49138B (sh) 1990-06-01 1991-05-29 Proteinski derivat humane lipaze stimulisane žučnom soli
DE69125489T DE69125489T2 (de) 1990-06-01 1991-05-30 Verwendung von derivaten durch menschliches gallensalz stimulierter lipase zur herstellung von medikamenten
AU79645/91A AU651979B2 (en) 1990-06-01 1991-05-30 Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them
UA93003780A UA39165C2 (uk) 1990-06-01 1991-05-30 Молекула днк, що кодує ліпазу людини, що стимулюється солями жовчних кислот, клонована молекула кднк
AT91911030T ATE151077T1 (de) 1990-06-01 1991-05-30 Verwendung von derivaten durch menschliches gallensalz stimulierter lipase zur herstellung von medikamenten
JP91510382A JPH05507201A (ja) 1990-06-01 1991-05-30 新規な化学的生成物
HU9203774A HU215258B (hu) 1990-06-01 1991-05-30 Eljárás rekombináns, humán epesó által stimulált lipázszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
DK91911030.4T DK0535048T3 (da) 1990-06-01 1991-05-30 Derivater af humant galdesalt-stimuleret lipase og farmaceutiske præparater indeholdende disse
ES91911030T ES2099159T3 (es) 1990-06-01 1991-05-30 Uso de derivados de lipasa estimulada por sales biliares humanas para la preparacion de medicamentos.
PL91296937A PL166534B1 (pl) 1990-06-01 1991-05-30 Sposób wytwarzania bialka PL PL PL PL PL PL
SG1996006887A SG48078A1 (en) 1990-06-01 1991-05-30 Derivatives of human bile-salt stimulated lipase and pharmaceutical compositions containing them
IE184491A IE911844A1 (en) 1990-06-01 1991-05-30 New chemical products
PCT/SE1991/000381 WO1991018923A1 (en) 1990-06-01 1991-05-30 Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them
RO92-01490A RO114793B1 (ro) 1990-06-01 1991-05-30 Peptida derivata de lipaza umana stimulata de sarea biliara si secventa de adn ce o codifica
RU92016526/13A RU2140983C1 (ru) 1990-06-01 1991-05-30 Молекула днк, кодирующая липазу человека, стимулируемую солями желчи
CA002083396A CA2083396C (en) 1990-06-01 1991-05-30 Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them
EP91911030A EP0535048B1 (en) 1990-06-01 1991-05-30 Use of derivatives of human bile-salt stimulated lipase for the preparation of medicaments
IS3710A IS1751B (is) 1990-06-01 1991-05-31 Aðferð við að framleiða samskeytt prótein
TNTNSN91041A TNSN91041A1 (fr) 1990-06-01 1991-05-31 Nouveaux produits chimiques
CS19911644A CZ287470B6 (cs) 1990-06-01 1991-05-31 Léčivo k ošetřování patologického stavu, souvisejícího s exokrinní pankreatickou nedostatečností
PT97836A PT97836B (pt) 1990-06-01 1991-05-31 Processo para a preparacao de novas proteinas e de composicoes farmaceuticas que as contem
SK1644-91A SK281089B6 (sk) 1990-06-01 1991-05-31 Dna sekvencie a proteíny vzťahujúce sa na lipázu stimulovanú žlčovou soľou, spôsob výroby proteínov, farmaceutické kompozície s ich obsahom a ich použitie
JO19911694A JO1694B1 (en) 1990-06-01 1991-06-01 New chemical products
CN91104368A CN1075113C (zh) 1990-06-01 1991-06-01 关于人消化酶的重组蛋白及其制备方法
APAP/P/1991/000270A AP207A (en) 1990-06-01 1991-06-01 New DNA sequences and proteins coded for such DNA sequences.
PH43285A PH30761A (en) 1990-06-01 1991-10-11 An infant formulation fortified with bile salt-activated lipase.
HRP-951/91A HRP920771B1 (en) 1990-06-01 1992-10-01 New chemical products
NO19924528A NO322962B1 (no) 1990-06-01 1992-11-24 Anvendelse av et rekombinant protein for fremstilling av et preparat for behandling av tilstander relatert til eksokrin bukspyttkjertelinsuffisiens
BG97123A BG61165B1 (bg) 1990-06-01 1992-11-26 Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
KR1019920703049A KR100212411B1 (en) 1990-06-01 1992-11-30 Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them
FI925453A FI114639B (fi) 1990-06-01 1992-11-30 Ihmisen sappisuolojen stimuloimat lipaasijohdannaiset ja menetelmä niitä sisältävän farmaseuttisen koostumuksen valmistamiseksi
LVP-93-1005A LV10292B (en) 1990-06-01 1993-07-30 Derivatives of human bile salt stimulated lipase and pharmaceutical compositions containing them
LTIP1736A LT4020B (en) 1990-06-01 1993-12-30 Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them
HK62497A HK62497A (en) 1990-06-01 1997-05-08 Use of derivatives of human bile-salt stimulated lipase for the preparation of medicaments
GR970401262T GR3023618T3 (en) 1990-06-01 1997-05-30 Use of derivatives of human bile-salt stimulated lipase for the preparation of medicaments
CN00130975A CN1326782A (zh) 1990-06-01 2000-11-20 关于人消化酶的重组蛋白及其制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9001985A SE9001985D0 (sv) 1990-06-01 1990-06-01 New chemical products

Publications (1)

Publication Number Publication Date
SE9001985D0 true SE9001985D0 (sv) 1990-06-01

Family

ID=20379662

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9001985A SE9001985D0 (sv) 1990-06-01 1990-06-01 New chemical products

Country Status (44)

Country Link
EP (1) EP0535048B1 (bg)
JP (1) JPH05507201A (bg)
KR (1) KR100212411B1 (bg)
CN (2) CN1075113C (bg)
AP (1) AP207A (bg)
AT (1) ATE151077T1 (bg)
AU (1) AU651979B2 (bg)
BG (1) BG61165B1 (bg)
CA (1) CA2083396C (bg)
CZ (1) CZ287470B6 (bg)
DE (1) DE69125489T2 (bg)
DK (1) DK0535048T3 (bg)
DZ (1) DZ1503A1 (bg)
EG (1) EG19937A (bg)
ES (1) ES2099159T3 (bg)
FI (1) FI114639B (bg)
GR (1) GR3023618T3 (bg)
HK (1) HK62497A (bg)
HR (1) HRP920771B1 (bg)
HU (1) HU215258B (bg)
IE (1) IE911844A1 (bg)
IL (1) IL98273A (bg)
IS (1) IS1751B (bg)
JO (1) JO1694B1 (bg)
LT (1) LT4020B (bg)
LV (1) LV10292B (bg)
MA (1) MA22166A1 (bg)
MY (1) MY111245A (bg)
NO (1) NO322962B1 (bg)
NZ (1) NZ238223A (bg)
PH (1) PH30761A (bg)
PL (1) PL166534B1 (bg)
PT (1) PT97836B (bg)
RO (1) RO114793B1 (bg)
RU (1) RU2140983C1 (bg)
SE (1) SE9001985D0 (bg)
SG (1) SG48078A1 (bg)
SK (1) SK281089B6 (bg)
TN (1) TNSN91041A1 (bg)
TW (1) TW221712B (bg)
UA (1) UA39165C2 (bg)
WO (1) WO1991018923A1 (bg)
YU (1) YU49138B (bg)
ZA (1) ZA913778B (bg)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616483A (en) * 1992-06-11 1997-04-01 Aktiebolaget Astra Genomic DNA sequences encoding human BSSL/CEL
SE9300686D0 (sv) 1993-03-01 1993-03-01 Astra Ab Novel polypeptides
IS4130A (is) * 1993-03-01 1994-09-02 Ab Astra Ný fjölpeptíð
FR2754827B1 (fr) * 1996-10-17 1998-12-24 Biocem Lipases pancreatiques et/ou colipases recombinantes et polypeptides dervies produits par les plantes, leurs procedes d'obtention et leurs utilisations
JP2000026311A (ja) 1998-07-02 2000-01-25 Amano Pharmaceut Co Ltd 胃排出能亢進剤組成物
US20090226904A1 (en) * 2005-12-01 2009-09-10 University Of Bergen Diagnosis and treatment of exocrine pancreatic dysfunction and diabetes
US20130209436A1 (en) * 2010-04-23 2013-08-15 Synageva Biopharma Corp. Lysosomal storage disease enzymes
BR112013005673B1 (pt) 2010-09-09 2020-12-15 Alexion Pharmaceuticals, Inc Uso de lipase ácida lisossomal (lal) humana recombinante no tratamento da deficiência de lipase ácida lisossomal
CA2812852A1 (en) 2010-10-21 2012-04-26 Swedish Orphan Biovitrum Ab (Publ) Method to increase the absorption of unsaturated fatty acids by human infants
ES2603328T3 (es) 2010-10-21 2017-02-27 Swedish Orphan Biovitrum Ab (Publ) Método para incrementar la tasa de crecimiento de lactantes humanos
UY37680A (es) * 2017-06-19 2019-01-31 Swedish Orphan Biovitrum Ab Publ Proteína de fusión con polipéptido de extensión de vida media
JP2022545718A (ja) 2019-08-30 2022-10-28 コデクシス， インコーポレイテッド 操作されたリパーゼ改変体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000381A1 (en) * 1983-07-01 1985-01-31 Celltech Limited Proteins, pharmaceutical compositions, genes, vectors, host organisms and processes for their production

Also Published As

Publication number Publication date
YU95191A (sh) 1994-06-10
RU2140983C1 (ru) 1999-11-10
CN1326782A (zh) 2001-12-19
IS1751B (is) 2000-07-21
PT97836A (pt) 1992-02-28
EP0535048B1 (en) 1997-04-02
AU651979B2 (en) 1994-08-11
KR100212411B1 (en) 1999-08-02
CN1075113C (zh) 2001-11-21
EP0535048A1 (en) 1993-04-07
TW221712B (bg) 1994-03-11
NO924528D0 (no) 1992-11-24
ZA913778B (en) 1992-02-26
DE69125489D1 (de) 1997-05-07
DK0535048T3 (da) 1997-09-29
SK164491A3 (en) 1995-07-11
LT4020B (en) 1996-08-26
IE911844A1 (en) 1991-12-04
HK62497A (en) 1997-05-16
CZ164491A3 (cs) 1999-07-14
LV10292A (lv) 1994-10-20
CA2083396A1 (en) 1991-12-02
LV10292B (en) 1995-08-20
ATE151077T1 (de) 1997-04-15
BG97123A (bg) 1993-12-24
SG48078A1 (en) 1998-04-17
CA2083396C (en) 2006-09-19
AP207A (en) 1992-08-18
HU215258B (hu) 1998-11-30
HRP920771A2 (en) 1997-04-30
ES2099159T3 (es) 1997-05-16
NO322962B1 (no) 2006-12-18
AU7964591A (en) 1991-12-31
MA22166A1 (fr) 1991-12-31
SK281089B6 (sk) 2000-11-07
PH30761A (en) 1997-10-17
BG61165B1 (bg) 1997-01-31
WO1991018923A1 (en) 1991-12-12
HUT63184A (en) 1993-07-28
FI925453A0 (fi) 1992-11-30
PL166534B1 (pl) 1995-05-31
AP9100270A0 (en) 1991-07-31
HRP920771B1 (en) 1999-10-31
PT97836B (pt) 1998-11-30
EG19937A (en) 2000-12-31
LTIP1736A (en) 1995-08-25
NZ238223A (en) 1993-05-26
MY111245A (en) 1999-10-30
IL98273A0 (en) 1992-06-21
NO924528L (no) 1992-11-24
GR3023618T3 (en) 1997-08-29
CZ287470B6 (cs) 2000-12-13
JPH05507201A (ja) 1993-10-21
IS3710A7 (is) 1991-12-02
RO114793B1 (ro) 1999-07-30
HU9203774D0 (en) 1993-03-29
YU49138B (sh) 2004-03-12
UA39165C2 (uk) 2001-06-15
CN1064313A (zh) 1992-09-09
JO1694B1 (en) 1992-08-09
IL98273A (en) 2005-11-20
FI925453A (fi) 1992-11-30
DZ1503A1 (fr) 2004-09-13
FI114639B (fi) 2004-11-30
TNSN91041A1 (fr) 1992-10-25
DE69125489T2 (de) 1997-08-14

Similar Documents

Publication Publication Date Title
SE9001985D0 (sv) New chemical products
IT8719659A0 (it) Procedimento per la preparazione di collageno e prodotti cosi'ottenuto.
IT1206311B (it) Agente terapeutico a base di oligonucleotide e metodi per laproduzione dello stesso.
IT1187684B (it) Procedimento per la preparazione di fluoroelastomeri vulcanizzabili e prodotti cosi' ottenuti
CY1105398T1 (el) 5΄ ESTs ΓΙΑ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΠΟΥ ΕΚΦΡΑΖΟΝΤΑΙ ΣΕ ΔΙΑΦΟΡΟΥΣ ΙΣΤΟΥΣ
WO1998014592A3 (en) Telomerase reverse transcriptase
EP0885881A3 (en) Sulfonylalkanoylamino hydroxyethylamino sulfamic acids useful as retroviral protease inhibitors
ES543443A0 (es) Un metodo para la produccion de un preparado cosmetico a base de un diester de dioles y acidos dioicos c4-10.
CA2140545A1 (en) Use of first runnings coconut fatty acid as insect-repellent
HUP0001693A2 (hu) Alfa-hidroxisavak és/vagy aromás o-hidroxisavak alacsony molekulatömegű oligomer észtereinek alkalmazása kozmetikai készítményekben
ATE73462T1 (de) Hirudin-variante, deren verwendung und herstellung.
AU6584994A (en) Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
IT1226859B (it) Procedimento per la preparazione di acidi fosfinici utilizzati nella preparazione di inibitori di ace ed intermedi cosi' prodotti.
DE69613454T2 (de) Glucuronylarabinarate, Verfahren zu ihrer Herstellung und Anwendungen dieser Produkte
EP1222862A3 (de) Lösungen aus Propionsäure, Ammoniak, Propandiol und Wasser und deren Verwendung
DK0550783T3 (da) Anvendelse af diolestere i hunde- og kattefoder
Gharavi Molecular cloning of the human lipoxygenase gene
Hoke Quailing over clean air.
IT8820978A0 (it) Composizione erbicida conselettivita' aumentata e processo per la preparazione di entrambi i componenti ingredienti attivi in un solo stadio.
Tangley et al. Soviet Science
WO2001036458A3 (en) Drosophila ced-6 homologue
TH46357A (th) การเสนอสารซึ่งมีฤทธิ์ทางชีวภาพ
IT234199Y1 (it) Cannula vaginale,particolarmente studiata per l'utilizzazione di pomate e di prodotti medicamentosi in genere
ITBO920133A1 (it) Procedimento per la realizzazione di prodotti ceramici antistatici, in particolare piastrelle e prodotto cosi' ottenuto
RU99114027A (ru) Нуклеиново-кислотные и аминокислотные последовательности helicobacter pylory и их вакцинные композиции